Literature DB >> 29146607

Proof of concept that most borderline Quantiferon results are true antigen-specific responses.

Jonathan W Uzorka1,2, Lucia J M Kroft3, Jaap A Bakker4, Erik W van Zwet5, Erik Huisman6, Corine Knetsch-Prins1, Cornelis J van der Zwan7, Tom H M Ottenhoff1, Sandra M Arend8.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 29146607     DOI： 10.1183/13993003.01630-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  6 in total

1.  The Impact of Borderline Quantiferon-TB Gold Plus Results for Latent Tuberculosis Screening under Routine Conditions in a Low-Endemicity Setting.

Authors:  A Wikell; J Jonsson; R Dyrdak; A J Henningsson; A Eringfält; T Kjerstadius; E Hålldin; H Baqir; V Kholod; E Sturegård; J Bruchfeld; T Schön
Journal:  J Clin Microbiol       Date:  2021-09-22       Impact factor: 5.948

2.  Trends in diagnostic methods and treatment of latent tuberculosis infection in a tertiary care center from 2000 to 2017.

Authors:  Jonathan W Uzorka; Dinah L Duinkerk; Lucia J M Kroft; Jaap A Bakker; Rajen S R S Ramai; Tom H M Ottenhoff; Sandra M Arend
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-02-20       Impact factor: 3.267

3.  Abnormalities suggestive of latent tuberculosis infection on chest radiography; how specific are they?

Authors:  Jonathan W Uzorka; Lucia J M Kroft; Jaap A Bakker; Erik W van Zwet; Erik Huisman; Corine Prins; Cornelis J van der Zwan; Tom H M Ottenhoff; Sandra M Arend
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2019-01-25

4.  TST conversions and systemic interferon-gamma increase after methotrexate introduction in psoriasis patients.

Authors:  Vanessa Lucília Silveira de Medeiros; Fabiana Cristina Fulco Santos; Lílian Maria Lapa Montenegro; Maria da Conceição Silva; Valdênia Maria Oliveira de Souza; Reginaldo Gonçalvez de Lima Neto; Líbia Cristina Rocha Vilela Moura; Vera Magalhães
Journal:  PLoS One       Date:  2020-12-03       Impact factor: 3.240

5.  Biomarkers to identify Mycobacterium tuberculosis infection among borderline QuantiFERON results.

Authors:  Jonathan W Uzorka; Jaap A Bakker; Krista E van Meijgaarden; Eliane M S Leyten; Nathalie M Delfos; David J Hetem; Jos Kerremans; Mieke Zwarts; Sandra Cozijn; Tom H M Ottenhoff; Simone A Joosten; Sandra M Arend
Journal:  Eur Respir J       Date:  2022-08-10       Impact factor: 33.795

6.  Effect of HIV-infection on QuantiFERON-plus accuracy in patients with active tuberculosis and latent infection.

Authors:  Elisa Petruccioli; Teresa Chiacchio; Assunta Navarra; Valentina Vanini; Gilda Cuzzi; Claudia Cimaglia; Luigi Ruffo Codecasa; Carmela Pinnetti; Niccolò Riccardi; Fabrizio Palmieri; Andrea Antinori; Delia Goletti
Journal:  J Infect       Date:  2020-02-22       Impact factor: 6.072
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.